• Strategy
  • Payers
  • AI
  • Cybersecurity
  • Device Development
  • Studies/Published Research
  • Ethics
  • Regulatory
  • Digital Biomarkers
  • Data Science
  • Companion Diagnostics
  • Clinical Care
  • Digital Therapeutics
  • Academic Research
  • Virtual Reality
  • RWE
  • Digital Endpoints
  • Medical Devices (Class II and Class III)
  • Commercialization
  • Clinical Trials
  • Drug-Device Combinations
  • SaMD
  • Remote Patient Monitoring
  • Patient Engagement
  • Profiles/Q&A

Increasing the Adoption of Actigraphy Sensors and PSG Devices for Sleep-Disorders

Article

Actigraphy sensors are advanced medical devices used to understand sleep patterns and determines whether sleep is sufficient or insufficient and also monitor the health of users and diagnose sleep-related diseases. Polysomnography (PSG) is a primary standard used for evaluating sleep patterns as it determines sleep-time, wake-time, and sleep schedule structure. People’s busy lifestyles have made an impact on their sleep health, increasing the prevalence of sleeping disorders and the demand for actigraphy sensors and PSG devices.
Read more about this news release here.

© 2024 MJH Life Sciences

All rights reserved.